Law ❯ Litigation ❯ Securities Law ❯ Class Action

Securities Fraud

March 9 Deadline Set for Investors to Seek Lead Role in Ardent Health Securities Class Action

Plaintiffs say Ardent misled investors on receivable collectability with a 180‑day cliff, understating malpractice risk.

BellRing Faces Securities Class Action in SDNY Over Alleged Misstatements on Demand

Alexandria Real Estate Investors Face Jan. 26 Deadline in Securities Class Action Lead-Plaintiff Bids

Bath & Body Works Faces Investor Class Action Over 'Adjacencies' Claims With Lead‑Plaintiff Motions Due in March

Ardent Health Investors Press Securities Case as Firms Seek Lead Plaintiff by March 9

Vistagen Faces Federal Securities Class Action After Fasedienol Phase 3 Failure

Alexandria Real Estate Class Action Intensifies Ahead of Jan. 26 Lead-Plaintiff Deadline

StubHub Investors Face Jan. 23 Deadline in IPO Disclosure Class Action

Stride Investors Face Jan. 12 Deadline in Securities Class Action Over Enrollment Claims and Tech Failure

Stride Securities Fight Intensifies as Firms Urge Investors to Meet Jan. 12 Lead-Plaintiff Deadline

Inspire Medical Investors Face Monday Deadline in Class Action Over Inspire V Rollout

Lead-Plaintiff Deadline Looms in Synopsys Securities Case

Alexandria Real Estate Investors Urged to Seek Lead Role in Securities Suit Before Jan. 26 Deadline

F5 Investors Urged to Seek Lead Role in Cyber Disclosure Suit as Feb. 17 Deadline Nears

CarMax Securities Suits Intensify as Jan. 2 Lead‑Plaintiff Deadline Nears

Synopsys Investors Face Dec. 30 Deadline in Securities Class Action

CarMax Securities Suit Advances as Jan. 2 Lead‑Plaintiff Deadline Nears

Lead-Plaintiff Deadline Nears in James Hardie Securities Class Action

Integer Holdings Faces Investor Class Action Over EP Device Demand Claims

Law Firms Urge Investors to Seek Lead Role in Alexandria Real Estate Securities Suit